Cargando…
A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function
Heart Failure with preserved Ejection Fraction (HFpEF) represents a major public health problem. The causative mechanisms are multifactorial and there are no effective treatments for HFpEF, partially attributable to the lack of well-established HFpEF animal models. We established a feline HFpEF mode...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707379/ https://www.ncbi.nlm.nih.gov/pubmed/29185443 http://dx.doi.org/10.1038/s41598-017-15851-2 |
_version_ | 1783282406630883328 |
---|---|
author | Wallner, Markus Eaton, Deborah M. Berretta, Remus M. Borghetti, Giulia Wu, Jichuan Baker, Sandy T. Feldsott, Eric A. Sharp, Thomas E. Mohsin, Sadia Oyama, Mark A. von Lewinski, Dirk Post, Heiner Wolfson, Marla R. Houser, Steven R. |
author_facet | Wallner, Markus Eaton, Deborah M. Berretta, Remus M. Borghetti, Giulia Wu, Jichuan Baker, Sandy T. Feldsott, Eric A. Sharp, Thomas E. Mohsin, Sadia Oyama, Mark A. von Lewinski, Dirk Post, Heiner Wolfson, Marla R. Houser, Steven R. |
author_sort | Wallner, Markus |
collection | PubMed |
description | Heart Failure with preserved Ejection Fraction (HFpEF) represents a major public health problem. The causative mechanisms are multifactorial and there are no effective treatments for HFpEF, partially attributable to the lack of well-established HFpEF animal models. We established a feline HFpEF model induced by slow-progressive pressure overload. Male domestic short hair cats (n = 20), underwent either sham procedures (n = 8) or aortic constriction (n = 12) with a customized pre-shaped band. Pulmonary function, gas exchange, and invasive hemodynamics were measured at 4-months post-banding. In banded cats, echocardiography at 4-months revealed concentric left ventricular (LV) hypertrophy, left atrial (LA) enlargement and dysfunction, and LV diastolic dysfunction with preserved systolic function, which subsequently led to elevated LV end-diastolic pressures and pulmonary hypertension. Furthermore, LV diastolic dysfunction was associated with increased LV fibrosis, cardiomyocyte hypertrophy, elevated NT-proBNP plasma levels, fluid and protein loss in pulmonary interstitium, impaired lung expansion, and alveolar-capillary membrane thickening. We report for the first time in HFpEF perivascular fluid cuff formation around extra-alveolar vessels with decreased respiratory compliance. Ultimately, these cardiopulmonary abnormalities resulted in impaired oxygenation. Our findings support the idea that this model can be used for testing novel therapeutic strategies to treat the ever growing HFpEF population. |
format | Online Article Text |
id | pubmed-5707379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-57073792017-12-06 A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function Wallner, Markus Eaton, Deborah M. Berretta, Remus M. Borghetti, Giulia Wu, Jichuan Baker, Sandy T. Feldsott, Eric A. Sharp, Thomas E. Mohsin, Sadia Oyama, Mark A. von Lewinski, Dirk Post, Heiner Wolfson, Marla R. Houser, Steven R. Sci Rep Article Heart Failure with preserved Ejection Fraction (HFpEF) represents a major public health problem. The causative mechanisms are multifactorial and there are no effective treatments for HFpEF, partially attributable to the lack of well-established HFpEF animal models. We established a feline HFpEF model induced by slow-progressive pressure overload. Male domestic short hair cats (n = 20), underwent either sham procedures (n = 8) or aortic constriction (n = 12) with a customized pre-shaped band. Pulmonary function, gas exchange, and invasive hemodynamics were measured at 4-months post-banding. In banded cats, echocardiography at 4-months revealed concentric left ventricular (LV) hypertrophy, left atrial (LA) enlargement and dysfunction, and LV diastolic dysfunction with preserved systolic function, which subsequently led to elevated LV end-diastolic pressures and pulmonary hypertension. Furthermore, LV diastolic dysfunction was associated with increased LV fibrosis, cardiomyocyte hypertrophy, elevated NT-proBNP plasma levels, fluid and protein loss in pulmonary interstitium, impaired lung expansion, and alveolar-capillary membrane thickening. We report for the first time in HFpEF perivascular fluid cuff formation around extra-alveolar vessels with decreased respiratory compliance. Ultimately, these cardiopulmonary abnormalities resulted in impaired oxygenation. Our findings support the idea that this model can be used for testing novel therapeutic strategies to treat the ever growing HFpEF population. Nature Publishing Group UK 2017-11-29 /pmc/articles/PMC5707379/ /pubmed/29185443 http://dx.doi.org/10.1038/s41598-017-15851-2 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Wallner, Markus Eaton, Deborah M. Berretta, Remus M. Borghetti, Giulia Wu, Jichuan Baker, Sandy T. Feldsott, Eric A. Sharp, Thomas E. Mohsin, Sadia Oyama, Mark A. von Lewinski, Dirk Post, Heiner Wolfson, Marla R. Houser, Steven R. A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function |
title | A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function |
title_full | A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function |
title_fullStr | A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function |
title_full_unstemmed | A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function |
title_short | A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function |
title_sort | feline hfpef model with pulmonary hypertension and compromised pulmonary function |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707379/ https://www.ncbi.nlm.nih.gov/pubmed/29185443 http://dx.doi.org/10.1038/s41598-017-15851-2 |
work_keys_str_mv | AT wallnermarkus afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT eatondeborahm afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT berrettaremusm afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT borghettigiulia afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT wujichuan afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT bakersandyt afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT feldsotterica afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT sharpthomase afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT mohsinsadia afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT oyamamarka afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT vonlewinskidirk afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT postheiner afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT wolfsonmarlar afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT houserstevenr afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT wallnermarkus felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT eatondeborahm felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT berrettaremusm felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT borghettigiulia felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT wujichuan felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT bakersandyt felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT feldsotterica felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT sharpthomase felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT mohsinsadia felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT oyamamarka felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT vonlewinskidirk felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT postheiner felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT wolfsonmarlar felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction AT houserstevenr felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction |